SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--Nov. 15, 2005--FzioMed, Inc. announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase I grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (NIH) to support development of a novel injectable product for acceleration of bone healing in spinal fusion procedures.
